Results for the Third Quarter 2017

Currency neutral growth of own products is 12.5%. Flow probe sales negatively impacted with MNOK 2.2, however, production of flow probe capacity is improving and backorder is reduced from 500 to 250 probes. Another strong…

Read more

Medistim has received clearance for sale of MiraQ™ in China

MiraQ™ represents Medistim's most advanced system for ultrasonic surgical guidance and quality assessment used intraoperatively during coronary artery bypass grafting (CABG) as well as vascular and transplant surgery. The system combines state-of-the-art transit time blood…

Read more

Medistim Establishes Own Subsidiary in Spain

Annually, around 7.000 coronary artery bypass surgery (CABG) procedures and 8.000 vascular procedures are performed throughout the 56 cardiac centers and 75 vascular centers in Spain. Medistim currently has an installed base of 80 systems,…

Read more

Medistim introduces the SonoQ™ to the Indian market

Medistim launches the SonoQ™ at the ICC congress in New Delhi, India 11-13 November 2016 “Medistim is the market leader with high-end products for surgical guidance and blood flow measurement in cardiac-, vascular and transplant surgery…

Read more

Medistim Launches the MiraQ™ Vascular System

Medistim launches the newest product on the MiraQ™ quality assessment platform - The MiraQ™ Vascular System- specifically for vascular surgery. The system is introduced for the first time at the ESVS annual meeting in Porto,…

Read more